We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 123

Federal court affirms standing for innovative drug manufacturer

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • July 23 2014

What rights do innovative drug manufacturers have in situations where generics challenge certain Health Canada decisions but do not name the

AstraZeneca v. Apotex; interlocutory motion for reply evidence; esomeprazole

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • February 12 2010

The Court dismissed AstraZeneca's appeal from the order of a prothonotary refusing to strike parts of Apotex' evidence and refusing to permit the applicants to file reply

Janssen-Ortho v. Apotex; interlocutory motion for reply evidence; methylphenidate

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • February 12 2010

In two NOC proceedings, the order of evidence was reversed

Eli Lilly and Company successful in patent infringement action against Apotex

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 2 2009

On October 1, 2009, Justice Gauthier of the Federal Court of Canada rendered a decision upholding the validity of eight process patents relating to intermediates used in the production of the antibiotic cefaclor

Solvay v Apotex; 55.2 proceeding; motion to file reply evidence - pantoprazole

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • September 13 2007

The applicants sought to file two further affidavits in reply

AstraZeneca v Novopharm, motion to adduce video-recordings of cross-examinations of expert witnesses in a PMNOC Regulations case

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

AstraZeneca brought a motion seeking an order that video-recordings of cross-examinations of expert witnesses in the proceedings be filed as part of the Application Record and available at the hearing

Canada (Attorney General) v. Celgene Corporation, appeal of a PMPRB decision

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • January 20 2010

The Court of Appeal overturned the decision of the Trial Judge and restored the decision of the PMPRB providing jurisdiction to the PMPRB over medicines imported under the Special Access Program

Sanofi-Aventis v. Laboratoire Riva; interlocutory motion on 55.2 proceeding; December 14, 2007 - Ramipril

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • January 17 2008

After cross-examinations had taken place, and approximately one week before the application record of Sanofi-Aventis was due, Riva brought a motion for leave to file further evidence

Recent cases

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • August 21 2009

The Court granted an order of prohibition to Purdue in the face of Pharmascience’s allegations that the patent was invalid

Lundbeck v. Cobalt, Genpharm and Apotex

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • April 7 2009

The Court granted prohibition in respect of each of the proceedings against each defendant